Brain atrophy in cerebral small vessel diseases: Extent, consequences, technical limitations and perspectives: The HARNESS initiative

J Cereb Blood Flow Metab. 2020 Feb;40(2):231-245. doi: 10.1177/0271678X19888967. Epub 2019 Nov 20.

Abstract

Brain atrophy is increasingly evaluated in cerebral small vessel diseases. We aim at systematically reviewing the available data regarding its extent, correlates and cognitive consequences. Given that in this context, brain atrophy measures might be biased, the first part of the review focuses on technical aspects. Thereafter, data from the literature are analyzed in light of these potential limitations, to better understand the relationships between brain atrophy and other MRI markers of cerebral small vessel diseases. In the last part, we review the links between brain atrophy and cognitive alterations in patients with cerebral small vessel diseases.

Keywords: Cerebral small vessel disease; brain atrophy; brain volume; cognitive alterations; cognitive performances; lacunes; segmentation; white matter hyperintensities.

Publication types

  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Atrophy
  • Brain* / blood supply
  • Brain* / diagnostic imaging
  • Brain* / pathology
  • Cerebral Small Vessel Diseases* / diagnostic imaging
  • Cerebral Small Vessel Diseases* / pathology
  • Cognitive Dysfunction* / diagnostic imaging
  • Cognitive Dysfunction* / pathology
  • Female
  • Humans
  • Magnetic Resonance Imaging*
  • Male